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1. INTRODUCTION1-8 
 
Introduction to Analytical Chemistry 
Analytical Chemistry is defined as the “science and the art of determining the composition 
of materials in terms of the elements or compounds contained”.  This branch of chemistry, 
which is both theoretical, and a practical science, is practiced in a large number of 
laboratories in many diverse ways while analytical method, is a specific application of a 
technique to solve an analytical problem. Methods of analysis are routinely developed, 
improved and validated.collaboratively studied and applied. In analytical chemistry it is of 
prime importance to gain information about the qualitative and quantitative composition 
of substances and chemical species, that is, to find out what a substance is composed and 
exactly how much. In quantitative analysis the question is how much is present? The 
research work in this thesis is based on this criterion.  
Instrumental methods of Chemical analysis 
Instrumental method is an exciting and fascinating part of chemical analysis that interacts 
with all areas of chemistry and with many other areas of pure and applied sciences. 
Analytical instrumentation plays an important role in the production and evaluation of 
new products and in the protection of consumers and environment. This instrumentation 
provides lower detection limits required to assure safe foods, drugs, water and air. 
Instrumental methods are widely used by Analytical chemists to save time, to avoid 
chemical separation and to obtain increased accuracy. 
Most instrumental techniques fit into one of the four-principle areas mentioned below. 
Spectrophotometric techniques 
 UV and Visible Spectrophotometry 
 Fluorescence and Phosphorescence Spectrophotometry 
 Atomic Spectrophotometry (emission &absorption) 
 Infrared Spectrophotometry 
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 Raman Spectrophotometry 
 X-Ray Spectrophotometry 
 Nuclear Magnetic Resonance Spectroscopy 
 Mass Spectroscopy 
 Electron Spin Resonance Spectroscopy 
 
ElectrochemicalTechniques  
 Potentiometry 
 Voltametry 
 Electrogravimetry 
 Conductometry 
 Amperomertry 
 
Chromatographic Techniques 
 High Performance Liquid Chromatography  
 Gas chromatography  
 High Performance Thin Layer Chromatography  
 Thin Layer Chromatography  
 GC- MS (Gas chromatography - Mass Spectroscopy 
 LC-MS (Liquid Chromatography - Mass Spectroscopy) 
Introduction to HPLC 
High Performance Liquid Chromatography (HPLC) is one mode of chromatography, one 
of the most used analytical techniques. Chromatographic process can be defined as 
separationtechnique involving mass-transfer between stationary and mobile phase. HPLC 
utilises a liquid mobile phase to separate the components of a mixture. The stationary 
phase can be a liquid or a solid phase. These components are first dissolved in a solvent, 
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and then forced to flow through a chromatographic column under a high pressure. In the 
column, the mixture separates into its components. 
The amount of resolution is important, and is dependent upon the extent of interaction 
between the solute components and the stationary phase. The stationary phase is defined 
as the immobile packing material in the column. The interaction of the solute with mobile 
and stationary phases can be manipulated through different choices of both solvents and 
stationary phases. As a result, HPLC acquires a high degree of versatility not found in 
other chromatographic systems and it has the ability to easily separate a wide variety of 
chemical mixtures. 
Principle 
Liquid chromatography is a separation method in which the components of a sample 
partition between two phases – one of these phases is a stationary bed with a large surface 
area and the other is a liquid which percolates through the stationary bed. The sample is 
carried by the mobile liquid phase through the column. Samples partition (equilibrate) into 
the stationary liquid phase, based on their solubility in the phases and/ or molecular size 
solubilities. The compounds of the sample separate from one another based on their 
affinities for the stationary bed. This type of chromatography process is called elution. 
Theory 
HPLC is a dynamic adsorption process. Analyte molecules, while moving through the 
porouspacking beads, tend to interact with the surface adsorption sites. Depending on the 
HPLC mode, the different types of the adsorption forces may be included in the retention 
process: 
1)Hydrophobic (non-specific) interactions are the main ones in reversed-phase (RP) 
separations. 
2) Dipole-dipole (polar) interactions are dominant in normal phase (NP). 
3)Ionic interactions are responsible for the retention in ion-exchangechromatography. 
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All these interactions are competitive. Analyte molecules are competing with the eluent 
molecules for the adsorption sites. So, the stronger analyte molecules interact with the 
surface. The weaker the eluent interaction, the longer the analyte will be retained on the 
surface. SEC (size-exclusion chromatography)is another case. It is the separation of the 
mixture by the molecular size of its components. The basic principle of SEC separation is 
that the bigger the molecule, the less possibility there is for it to penetrate into the 
adsorbent pore space. So, the bigger the molecule 
Stationary Phases (Adsorbents) 
HPLC separations are based on the surface interactions, and depend on the types of 
theadsorption sites. Modern HPLC adsorbents are the small rigid porous particles with 
high surface area. 
Main adsorbent parameters are: 
Particle size: 3 to 10 µm 
Particle size distribution: as narrow as possible, usually within 10% of the mean; 
The last parameter in the list represents an adsorbent surface chemistry. 
Depending on the type of the ligand attached to the surface, the adsorbent could be normal 
phase (-OH, -NH2), or reversed-phase (C5, C8, C 18 CN, NH2 ), and even anion 
(CH2NR3+OH-), or cation (R-SO3\-H+) exchangers. 
Mobile Phases 
In HPLC, the type and composition of the eluent is one of the variables influencing the 
separation. Despite the large variety of solvents used in HPLC, there are several common 
properties: 
• Purity 
• Detector compatibility 
• Solubility of the sample 
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• Low viscosity 
• Chemical inertness 
For normal phase mode, solvents are mainly nonpolar; for reversed-phase, eluents are 
usually a mixture of water with some polar organic solvent such as acetonitrile or 
methanol. Size-exclusion HPLC has special requirements. SEC eluents have to dissolve 
polymers, but the most important is that SEC eluent has to suppress possible interactions 
of the sample molecule with the surface of the packing material. 
Instrumentation of HPLC system 
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Fig 2:  Pictorial Representation of HPLC Instrument 
 
HPLC instrumentation includes a pump, injector, column, detector and data system. The 
heart of the system is the column where separation occurs. Since the stationary phase is 
composed of micrometre size porous particles, a high pressure pump is required to move 
the mobile phase through the column. The chromatographic process begins by injecting 
the solute onto the top of the column. Separation of components occurs as the analytes and 
mobile phase are pumped through the column. Eventually, each component elutes from 
the column as a narrow band (or peak) on the recorder. 
Detection of the eluting components is important, and this can be either selective or 
universal,depending upon the detector used. The response of the detector to each 
component is displayed on a chart recorder or computer screen and is known as a 
chromatogram. To collect, store and analyse the chromatographic data, computer, 
integrator, and other data processing equipment arefrequently used. 
Components of HPLC: 
Mobile phase reservoir, filtering 
Pump 
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Injector 
Column 
Detector 
Data system 
 
Mobile Phase Reservoir, Filtering 
The most common type of solvent reservoir is a glass bottle. Most of the manufacturers 
supply these bottles with special caps, Teflon tubing and filters to connect to the pump 
inlet and to the purge gas (helium) used to remove dissolved air. Helium purging and 
storage of the solvent under helium is not sufficient for degassing aqueous solvents. It is 
useful to apply a vacuum for 5-10 min. and then keep the solvent under a helium 
atmosphere. 
Pump 
High pressure pumps are needed to force solvents through packed stationary phase beds. 
Smaller bed particles require higher pressures. There are many advantages to using 
smaller particles, but they may not be essential for all separations. 
The most important advantages are: higher resolution, faster analyses, and increased 
sample load capacity. However, only the most demanding separations require these 
advances in significant amounts. Many separation problems can be resolved with larger 
particle packings that require less pressure. Flow rate stability is another important pump 
feature that distinguishes pumps. Very stable flow rates are usually not essential for 
analytical chromatography. However, if the user plans to use a system in size exclusion 
mode, then there must be a pump which provides an extremely stable flow rate. 
An additional feature found on the more elaborate pumps is external electronic control. 
Although it adds to the expense of the pump, external electronic control is a very desirable 
feature when automation or electronically controlled gradients are to be run. Alternatively, 
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this becomes an undesirable feature (since it is an unnecessary expense) when using 
isocratic methods. The degree of flow control also varies with pump expense. More 
expensive pumps include such stateof- the-art technology as electronic feedback and 
multiheaded configurations. 
 
Modern pumps have the following parameters: 
• Flow rate range: 0.01 to 5 mL/min 
• Flow rate stability: not more than 1% 
• For SEC flow rate stability should be less than 0.2% 
• Maximum pressure: up to 300 hPa. 
• It is desirable to have an integrated degassing system, either helium purging, 
• or membrane filtering. 
Injector 
Sample introduction can be accomplished in various ways. The simplest method is to use 
aninjection valve. In more sophisticated LC systems, automatic sampling devices are 
incorporated where the sample is introduced with the help of autosamplers and 
microprocessors. In liquid chromatography, liquid samples may be injected directly and 
solid samples need only be dissolved in an appropriate solvent. The solvent need not be 
the mobile phase, but frequently it is judiciously chosen to avoid detector interference, 
column/component interference, loss in efficiency or all of these. It is always best to 
remove particles from the sample by filtering over a 5 µm filter, or centrifuging, since 
continuous injections of particulate material will eventually cause blockages in injection 
devices or columns.  
Sample sizes may vary widely. The availability of highly sensitive detectors frequently 
allows use of the small samples which yield the highest column performance. Typical 
sample mass with 4.6 mm ID columns range from the nanogram level up to about 2 mg 
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diluted in 20 ml of solvent. In general, it will be noted that much less sample preparation 
is required in LC than in GC since unwanted or interfering compounds, or both, may often 
be extracted, or eliminated, by selective detection. 
Column 
The HPLC Column holds the stationary phase for separating the components of the 
sample. The columns are usually made up of SS-316 grade steel. Apart from columns, the 
material of construction of tubing and fittings, plumbing and connections are also very 
critical. Apart from resistivity to corrosion, connections and plumbing should have a very 
low dead volume. Many different reverse phase columns will provide excellent specificity 
for any particular separation.  
It is therefore best to routinely attempt separations with a standard C8 or C18 column and 
determine if it provides good separations. If this column does not provide good separation 
or the mobile phase is unsatisfactory, alternate methods or columns should be explored. 
Reverse phase columns differ by the carbon chain length,degree of end capping and 
percent carbon loading.Diol, cyano and amino groups can also be used for reverse phase 
chromatography. 
Typical HPLC columns are 5, 10, 15 and 25 cm in length and are filled with small 
diameter (3, 5 or 10 µm) particles. The internal diameter of the columns is usually 4.6 
mm; this is considered the best compromise for sample capacity, mobile phase 
consumption, speed and resolution. However, if pure substances are to be collected 
(preparative scale), then larger diameter columns may be needed. Packing the column 
tubing with small diameter particles requires high skill and specialized equipment. For this 
reason, it is generally recommended that all but the most experienced chromatographers 
purchase prepacked columns, since it is difficult to match the high performance of 
professionally packed LC columns without a large investment in time and equipment. 
In general, LC columns are fairly durable and one can expect a long service life unless 
they are used in some manner which is intrinsically destructive, as for example, with 
highly acidic or basic eluents, or with continual injections of 'dirty' biological or crude 
samples. It is wise to inject some test mixture (under fixed conditions) into a column when 
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new, and to retain the chromatogram. If questionable results are obtained later, the test 
mixture can be injected again under specified conditions. The two chromatograms may be 
compared to establish whether or not the column is still useful. 
Detector 
Today, optical detectors are used most frequently in liquid chromatographic systems. 
These detectors pass a beam of light through the flowing column effluent as it passes 
through a lowvolume ( ~ 10 µl) flow cell. The variations in light intensity caused by UV 
absorption, fluorescence emission or change in refractive index, from the sample 
components passing through the cell, are monitored as changes in the output voltage. 
These voltage changes are recorded on a strip chart recorder and frequently are fed into a 
computer to provide retention time and peak area data. 
The following are the different detectors used in HPLC. 
Refractive Index (RI) detectors 
measure the ability of sample molecules to bend or refract light. This property for each 
molecule or compound is called its refractive index. For most RI detectors, light proceeds 
through a bi-modular flow-cell to a photodetector. One channel of the flow-cell directs the 
mobile phase passing through the column while the other directs only the mobile phase. 
Detection occurs when the light is bent due to samples eluting from the column, and this is 
read as a disparity between the two channels.  
Ultra-Violet (UV) Detectors 
measures the ability of a sample to absorb light. This can be accomplished at one or 
several wavelengths: A Fixed Wavelength measures at one wavelength, usually 254 nm. 
Variable Wavelength measures at one wavelength at a time, but can detect over a wide 
range of wavelengths. Diode Array measures a spectrum of wavelengths 
simultaneously.UV detectors have a sensitivity to approximately 10-8 or 10 -9 gm/ml.  
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Fluorescent Detectors 
measure the ability of a compound to absorb then re-emit light at given wavelengths. Each 
compound has a characteristic fluorescence. The excitation source passes through the 
flow-cell to a photodetector while a monochromator measures the emission wavelengths. 
Has sensitivity limit of 10-9 to 10-11 gm per mL. 
 
RadiochemicalDetection 
involves the use of radiolabeled material, usually tritium (3H) or carbon-14 (14C). It 
operates by detection of fluorescence associated with beta-particle ionization, and it is 
most popular in metabolite research. 
Data System 
Since the detector signal is electronic, using modern data collection techniques can aid the 
signal analysis. In addition, some systems can store data in a retrievable form for highly 
sophisticated computer analysis at a later time. The main goal in using electronic data 
systems is to increase analysis accuracy and precision, while reducing operator attention. 
There are several types of data systems, each differing in terms of available features. In 
routine analysis, where no automation (in terms of data management or process control) is 
needed, a pre-programmed computing integrator may be sufficient. If higher control levels 
are desired, a more intelligent device is necessary, such as a data station or minicomputer. 
The advantages of intelligent processors in chromatographs are found in several areas. 
First, additional automation options become easier to implement. Secondly, complex data 
analysis becomes more feasible. These analysis options include such features as run 
parameter optimisation and deconvolution (i.e. resolution) of overlapping peaks. Finally, 
software safeguards can be designed to reduce accidental misuse of the system. 
 
 
SELECTION OF CHROMATOGRAPHIC MODE  
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Reversed-phase chromatography (RPC), the most common mode for small organic 
molecules. Note that ionizable compounds (acids and bases) are often separated by RPC 
with buffered mobile phases (to keep the analytes in a non-ionized state) or with ion-
pairing reagents. In reverse phase mode, the mobile phase is comparatively more polar 
than the stationary phase. For the separation of polar or moderately polar compounds, the 
most preferred mode is reverse phase. The nature of the analyte is the primary factor in the 
selection of the mode of separation. A second factor is the nature of the matrix. 
 
CHOICE OF THE COLUMN 
Selection of the column is the first and the most important step in method development. 
The appropriate choice of separation column indicates three different approaches. 
 Selection of separation.  
 The particle size and nature of the column packing. 
 The physical parameters of the column i.e. the length and the diameter. 
Some of the important parameters considered while selecting chromatographic columns 
are 
 Length and diameter of the column  
 Packing material  
 Shape of the particles 
 Size of the particles 
 Pore volume 
 Surface area  
Reversed phase mode of chromatography facilities a wide range of columns covering wide 
range of polarities by cross linking silanol groups with alkyl chains like like dimethyl 
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silane (C2), butylsilane (C4), octylsilane(C8), octadecylsane (C18),base deactivated silane 
(C18), phenyl, cyanoproply (CN), nitro, amino etc.  
Silica based columns with different cross linkings in the increasing order of Polarity are as 
follows:  
<…………. Non-polar …………… moderately polar…………. Polar. ……> 
C18< C8< C6< Phenyl < Amino < Cyano<nitrile < Silica 
SELECTION OF MOBILE PHASE 
The primary objective in selection and optimization of mobile phase is to achieve 
optimum separation of all impurities and degradants from each other and from 
analytepeak.In liquid chromatography, the solute retention is governed by the solute 
distribution factor, which reflects the different interactions of the solute-stationary phase, 
solute-mobile phase, and mobile phase-stationary phase.  
The mobile phase has to be adapted in terms of elution strength (solute retention) and 
solvent selectivity (solute separation). Solvent polarity is the key word in chromatographic 
separations since a polar mobile phase will give rise to low solute retention in normal 
phase and high solute retention in reverse phase LC. The selectivity will be particularly 
altered if the buffer pH is close to the pka of the analytes. The following are the 
parameters, which shall be taken into consideration while selecting and optimizing the 
mobile phase. 
 Buffer and its strength 
 pH of the buffer or pH of the mobile phase 
 Selection of buffer 
 Mobile phase composition 
 
 
Chapter- 1                                                                                                 Introduction 
 
R.V.S. college of pharmaceutical sciencesPage no: 14 
 
A. BUFFERS, IF ANY, AND IT’S STRENGTH 
Buffer and its strength play an important role in deciding the peak symmetries and 
separations. Some of the most commonly employed buffers are 
• Phosphate buffers prepared using salts like KH2PO4, K2HPO4, NaH2PO4, Na2HPO4etc 
• Phosphoric acid buffers prepared using H3PO4. 
• Acetate buffers-Ammonium acetate, Sodium acetate etc. 
• Acetic acid buffers prepared using CH2COOH. 
 
The retention also depends on the molar strengths of the buffer-molar strength is inversely 
proportional to the retention times. Ideally the strength of the buffer shall be opted 
between 0.01M to 0.20M. After selecting the strength of the buffer, it can be varied by 
about 10-20% and the effect of variation was studied and it should be rugged for at least 
2% variation in strength. It is important to maintain the pH of the mobile phase in the 
range of 2.0 to 8.0 as most columns does not withstand to the pH which are outside this 
range. This is due to the fact that the silioxane linkages are cleaved below pH 2.0, while 
pH values above 8.0 the silica may dissolve. 
B. pH OF THE BUFFER 
pH plays an important role as it controls the elution properties by controlling the 
ionization characteristics. In RP-HPLC the retention of analytes is related to their 
hydrophobicity. The more hydrophobic the analyte, the longer it is retained. So, acid 
shows decrease in retention with increasing pH while base show increase in retention.  
 
 
 
C. SELECTION OF BUFFER 
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Optimum buffering capacity occurs at a pH equal to the pKa of the buffer. Almost all of 
the pH related change in retention occurs for pH values within ±1.5 units of pKa value. 
Outside this range the compound is either ionized or unionized, and its retention doesn’t 
change much with pH. 
The relationship between RPC retention and mobile phase pH is more complicated for 
compounds that contain multiple acidic and/or basic groups. If these groups are all same 
(acidic, basic) retention as a function of pH is similar. Buffer strength of 10-50 mM are 
generally adequate, but 25mM are compromise and suitable. The buffers showing UV 
absorbance below 220 nm were preferable.  An experiment was conducted using buffers 
having different pH to obtain the required separations. After reviewing the results, the pH 
was selected which is rugged for at least ±0.2 units of the selected pH. 
D. MOBILE PHASE COMPOSITION 
Most chromatographic separations can be achieved by choosing the optimum mobile 
phase composition. This is due to the fact that fairly large amount of selectivity can be 
achieved by choosing the qualitative and quantitative composition of aqueous and organic 
portions. Most widely used solvents in reverse phase chromatography are methanol and 
acetonitrile. Experiments should be conducted with mobile phases having buffers with 
different pH and different organic phases to check for the best separations of analyte peak. 
A mobile phase which gives separation of analyte peak and which is rugged for variation 
of both aqueous and organic phase by at least ± 0.2% of the selected mobile phase 
composition was used.The compounds can be further classified as neutral or ionic. 
Samples classified as ionic include acids, bases, amphoteric compounds and organic salts. 
If the sample is neutral, buffers or additives are generally not required in the mobile phase. 
Acids or bases usually require the addition of a buffer to the mobile phase. 
SELECTION OF FLOW RATE 
Generally flow rate shall not be more than 2.0 ml/min. the flow rate shall be selected 
based on the following data. 
• Retention time 
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• Column back pressure 
• Resolution between the peaks 
• Peak symmetries 
 The flow rate which gives least retention times, good peak symmetries, least back 
pressures and better separation will be selected. 
SELECTION OF DETECTOR 
The detector was chosen depending upon some characteristic property of the analyte like 
UV absorbance, florescence, conductance, oxidation, reduction etc. The characteristics 
that are to be fulfilled by a detector to be used in HPLC determination are, 
 High sensitivity facilitating trace analysis  
 Negligible baseline noise to facilitate lower detection  
 Large linear dynamic range 
 Low dead volume 
 Ease in calibration and standardization 
 Inexpensive to purchase and operate 
Pharmaceutical ingredients do not absorb all UV light equally, so that selection of 
detection wavelength is important. An understanding of the UV light absorptive properties 
of the organic impurities and the active pharmaceutical ingredient is very helpful. 
Generally LC equipped with PDA detector was the first choice. UV source like mercury 
vapour lamp is most widely used because majority of the compounds of pharmaceutical 
interest are absorbs at 250 – 270 nm and this lamp has an intense line spectrum at this 
region. 
 
OPTIMIZATION OF HPLC METHOD 
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During the optimization stage, the initial sets of conditions that have evolved from the first 
stages of development are improved or maximized in terms of resolution and peak shape, 
plate counts, asymmetry, capacity factor, elution time, detection limits, limit of 
quantitation and overall ability to quantify the specific analyte of interest. 
Optimization of a method can follow either of two general approaches: 
 Manual 
 Computer driven 
The manual approach involves varying one experimental variable at a time, while holding 
all other constant and recording changes in response. 
The variables might include flow rate, mobile or stationary phase composition, 
temperature, detection wavelength and PH.  
This univariate approach to system is slow, time consuming and potentially expensive. 
However, it may provide a much better understanding of the principles and theory 
involved and of interactions of the variables. 
In the second approach, computer driven automated method development, efficiency is 
optimized while experimental input is minimized. Computer driven automated approaches 
can be applied to many applications. In addition, they are capable of significantly reducing 
the time, energy and cost of all instrumental method development.  
VALIDATION9 
Validation of an analytical method is the process by which it is established by laboratory 
studies, that the performance characteristics of the method meet the requirements for the 
intended analytical applications. 
Validation is a basic requirement to ensure quality and reliability of the results for all 
analytical applications.  
Validation is defined as follows by different agencies: 
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European Committee (EC) 
Action of providing in accordance with the principles of good manufacturing practice that 
any procedure, process, equipment, material, activity or system actually leads to the 
expected results. In brief validationis a key process for effective Quality Assurance 
Food and Drug Administration (FDA) 
Provides a high degree of assurance that specific process will consistently produce a 
product meeting its predetermined specification and quality attributes. 
World Health Organization (WHO) 
Action of providing that any procedure, process, equipment, material, activity, or system 
actually leads to the expected results. 
Objective of Validation 
There are two important reasons for validating assays in the pharmaceutical industry. The 
first, and by for the most important, is that assay validation is an integral part of the 
quality-control system. 
The second is that current good manufacturing practice regulation requires assay 
validation. In industry it would be difficult to confirm that the product being manufactured 
is uniform and that meet the standards set to assure fitness for use. The varying nature of 
the differences between the analytical development laboratory and quality control 
laboratory is a good reason for validation program.  
 Method Validation10 
Method validation is the process of proving that an analytical method is acceptable for its 
intended purpose. For pharmaceutical methods, guidelines from the United States 
Pharmacopoeia (USP), International Conference on Harmonization (ICH), and the Food 
and Drug Administration (FDA) provide a framework for performing such validations. In 
general, methods for regulatory submission must include studies on specificity, linearity, 
accuracy, precision, range, detection limit, quantitation limit, and robustness. 
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Analytical Method needs to be Validated or Revalidated 
• Before their introduction into routine use.  Whenever the condition changes for which the 
method has been validated.  Example: sample with a different matrix, an instrument with 
different characteristics. 
• Whenever the method is changed and changes are outside the original scope of the 
method. 
Benefits of Method Validation8 
A fully validated process may require less in-process control and end product testing. It 
deepens the understanding of processes, decrease the risks of processing problems, and 
thus assure the smooth running of the process. 
VALIDATION PARAMETERS 
Accuracy  
Precision  
Specificity  
Limit of detection  
Limit of quantification 
Linearity and range 
Robustness  
System suitability  
 
 
Accuracy 
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Accuracy is the measure of exactness of an analytical method, or the closeness of 
agreement between the values, which is, accepted either as a conventional, true or 
accepted reference value, and the value found.   
Precision 
The precision of a method is the extent to which the individual test results of multiple 
injections of a series of standards agree.  
The measured standard deviation can be subdivided into 3 categories:  
 Repeatability 
 Intermediate precision  
 Reproducibility 
Repeatability      
Repeatability is obtained when the analysis is carried out in a laboratory by an operator 
using a piece of equipment over a relatively short time span. At least 6 determinations of 3 
different matrices at 2 or 3 different concentrations should be performed, and the RSD is 
calculated.  
Intermediate Precision  
Intermediate precision is a term that has been defined by ICH (4) as the long-term 
variability of the measurement process. It is determined by comparing the results of a 
method run within a single laboratory over a number of weeks. A method’s intermediate 
precision may reflect discrepancies in results obtained  
• From different operators,  
• From inconsistent working practice (thoroughness) of the same operator,  
• From different instruments,  
• With standards and reagents from different suppliers,  
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• With columns from different batches or  
• A combination of these.  
Specificity 
The terms selectivity and specificity are often used interchangeably. According to  ICH, 
the term specific generally refers to a method that produces a response for a single analyte 
only while the term selective refers to a method which provides responses for a number of 
chemical entities that may or may not be distinguished from each other. If the response is 
distinguished from all other responses, the method is said to be selective. Since there are 
very few methods that respond to only one analyte, the term selectivity is usually more 
appropriate.   
 
Reproducibility 
Reproducibility is defined by the precision obtained between different results laboratories. 
The objective is to verify that the method will provide the same in different laboratories. 
The reproducibility of an analytical method is determined by analyzing aliquots from 
homogeneous lots in different laboratories with different analysts, and by using 
operational and environmental conditions that may differ from, but are still within, the 
specified parameters of the method (inter laboratory tests). Validation of reproducibility is 
important if the method is to be used in different laboratories. 
Robustness 
The evaluation of robustness should be considered during   the development phase and 
depends on the type of procedure under study. It should show the reliability of an analysis 
with respect to deliberate variations in method parameters. 
Examples of typical variations are: 
•  Stability of analytical solutions 
•  Extraction time In the case of liquid chromatography, examples of typical variations  
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 Influence of variations of pH in a mobile phase 
 Influence of variations in mobile phase composition 
 Different columns (different lots and/or suppliers) 
  Temperature 
 Flow rate 
Limit of Detection (LOD) 
The limit of detection is the point at which a measured value is larger than the uncertainty 
associated with it. It is the lowest concentration of analyte in a sample that can be detected 
but not necessarily quantified. 
A. Based on Visual Evaluation 
Visual evaluation may be used for non-instrumental methods but may also be used with 
instrumental methods. The detection limit is determined by the analysis of samples with 
known concentrations of analyte and by establishing the minimum level at which the 
analyte can be reliably detected. 
B. Based on Signal-to-Noise 
This approach can only be applied to analytical procedures which exhibit baseline noise. 
Determination of the signal-to-noise ratio is performed by comparing measured signals 
from samples with known low concentrations of analyte with those of blank samples and 
establishing the minimum concentration at which the analyte can be reliably detected. A 
s/n ratio between 3 or 2:1 is generally considered acceptable for estimating the detection 
limit. 
 
 
C. Based on the Standard Deviation of the Response and the Slope 
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The detection limit (DL) may be expressed as: 
 
Where, 
                 σ = the standard deviation of the response 
               S = the slope of the calibration curve 
Limit of Quantification (LOQ) 
The limit of quantification is defined as the lowest concentration of an analyte in sample 
that can be determined with acceptable precision and accuracy under the stated operational 
conditions of the method. 
 
LINEARITY 
Linearity of an analytical procedure is its ability (within a given range) to obtain test 
results which are directly proportional the concentration (amount) of analyte in the 
sample. A linear relationship should be evaluated across the range of the analytical 
procedure. 
RANGE 
Range is the interval between the upper and lower concentration of the analyte in the 
sample for which it has a suitable level of precision, accuracy and linearity. 
 
 
 
SYSTEM SUITABILITY 
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 According to the USP, system suitability tests are an integral part of chromatographic 
methods. These tests are used to verify that the resolution and reproducibility of the 
system are adequate for the analysis to be performed. System suitability tests are based on 
the concept that the equipment, electronics, analytical operations, and samples constitute 
an integral system that can be evaluated as a whole.  The purpose of the system suitability 
test is to ensure that the complete testing system (including instrument, reagents, columns, 
analysts) is suitable for the intended application. 
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                                                       2. LITURATURE REVIEW 
 Srinivas N11,et al A highly selective, sensitive and accurate HPLC method has been 
developed and validated for the estimation of three fluoroquinolones (FQs) viz., 
gatifloxacin (GFC), sparfloxacin (SFC) and moxifloxacin (MFC) with 500 microL 
human plasma using levofloxacin (LFC) as an internal standard (IS). The sample 
preparation involved simple liquid-liquid extraction of GFC, SFC, MFC and IS from 
human plasma with ethyl acetate. The resolution of peaks was achieved with phosphate 
buffer (pH 2.5)-acetonitrile (80:20, v/v) at a flow rate of 1 mL/min on a KromasilC(18) 
column. The total chromatographic run time was 18.0 min and the simultaneous elution 
of GFC, SFC, MFC and IS occurred at approximately 10.8, 12.8, 17.0 and 6.0 min, 
respectively. The method proved to be accurate and precise at linearity range of 100-
10,000 ng/mL with a correlation coefficient (r) of > or =0.999. The limit of quantitation 
for each of the FQs studied was 100 ng/mL. The intra- and inter-day precision and 
accuracy values found to be within the assay variability limits as per the FDA guidelines. 
The developed assay method was applied to a pharmacokinetic study in human 
volunteers following oral administration of 400 mg GFC tablet. 
 
 Satish A. Patel12,et al A simple and sensitive high performance thin layer 
chromatographic method has been developed and validated for the simultaneous 
estimation of the levofloxacin and ornidazole in combined dosage forms. The stationary 
phase used was precoated silica gel 60F 254 plate. The mobile phase used was a mixture 
of n-butanol:  ethanol: ammonia (8 M) (5:0.5:1.5, v/v/v). The detection of spots was 
carried out densitometrically using a UV detector at 310 nm in absorbance mode. This 
system was found to give compact spots for levofloxacin (Rf value of 0.31 ± 0.003) and 
ornidazole (Rf value of 0.83 ± 0.008). The method was validated in terms of linearity, 
accuracy, precision, limit of detection, limit of quantification. The calibration curve was 
found to be linear between 40 to 140 and 80 to 280 ng/spot for levofloxacin and 
ornidazole, respectively with significantly high value of correlation coefficient (r 2 > 
0.99). The limits of detection and quantitation were found to be 9.98 and 30.25 ng/spot, 
respectively for levofloxacin and 21.12 and 64.01 ng/spot, respectively for ornidazole.  
Chapter -2                                                                            Literature review 
 
R.V.S. college of pharmaceutical sciencesPage no: 26 
 
 M. Senthil Raja13,et al A simple reverse phase liquid chromatographic method has been 
developed and subsequently validated for simultaneous determination of Azithromycin 
and Ambroxol Hydrochloride in combined dosage form. The separation was carried out 
using a mobile phase consisting of acetonitrile and mono basic potassium phosphate 
buffer of pH 8.5 in the ratio of 65:35 v/v. The column used was C18 phenomenex Gemini 
5m, 250cm x 4.6mm id with flow rate of 2ml/min using PDA detection at 220nm. The 
described method was linear over a concentration range of 96-145mg/ml and 80-
125mg/ml for the assay of Azithromycin and Ambroxol Hydrochloride respectively. The 
retention times of Ambroxol and Azithromycin were found to be 3.7min and 6.1min 
respectively. Results of analysis were validated statistically and by recovery studies. The 
limit of quantification (LOQ) for Azithromycin and Ambroxol Hydrochloride were found 
to be 96.7mg/ml and 8.35mg/ml respectively. Then the limit of detection (LOD) for 
Azithromycin and Ambroxol Hydrochloride were found to be 31.91 mg/ml and 2.75 
mg/ml respectively.  
 
 M. Sudheer14, et al A sensitive and specific isocratic RP-HPLC was developed for 
quantitative estimation of Azithromycin and AmbroxolHCl tablet formulation. The 
developed method consisting the mobile phase K2HPO4 – pH 6.5 :  (68 : 32) with 
isocratic programming, Hypersil, BDS, C 8, column (150 mm x 4.6 mm i.d., 5µm particle 
size) as stationary phase with a flow rate of 1.5 mL/minute by using λmax 215nm and 
PDA detector. Proposed method was found to be linear in the concentration range of 
100.0 to 360.0 µg/mL for Azithromycin and 15.0 to 54.0µg/mL for AmbroxolHCl 
respectively, the correlation coefficient was found to be 0.999. Precision study showed 
that the percentage relative standard deviation was within the range of acceptable limits, 
and the mean recovery was found to be 100.36 % for Azithromycin and 100.24% for 
AmbroxolHCl. The developed method was validated for specificity by stress studies. 
AmbroxolHCl and Azithromycin were subjected to stress condition and productswere 
analyzed by using photo diode array detector. It was found to be stable in milder 
condition of stress (0.1 M HCl, 0.1 M NaOH, 3% H2O2, at 60°C/10 minutes). The 
analyte peaks were well resolved from the degraded impurities. 
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 Mocho´n15,et al A spectrofluorimetric method to determine levofloxacin is proposed and 
applied to determine the substance in tablets and spiked human urine and serum. The 
fluorimetricmethod allow the determination of 20–3000 ng ml_1 of levofloxacin in 
aqueous solution containing acetic acid–sodium acetate buffer (pH 4) with lexc_292 and 
lem_494nm, respectively. Micelle enhanced fluorescence improves the sensibility and 
allows levofloxacin direct measurementin spiked Human serum (5 mg ml_1) and urine 
(420 mg ml_1), in 8 mM sodium dodecyl sulphate solutions at pH 5.  
 
 NájlaMohamad Kassab16,et al The objective of this research was to develop and 
validate an alternative analytical method for quantitative determination of levofloxacin in 
tablets and injection preparations. The calibration curves were linear over a concentration 
range from 3.0 to 8.0 µg mL-1. The relative standard deviation was below 1.0% for both 
formulations and average recovery was 101.42 ± 0.45% and 100.34 ± 0.85% for tablets 
and injection formulations, respectively. The limit of detection and limit of quantitation 
were 0.08 and 0.25 µg mL-1, respectively. It was concluded that the developed method is 
suitable for the quality control of levofloxacin in pharmaceuticals formulations. 
 
 BN Suhagia17,et al A simple and sensitive spectrophotometric method has been 
developed for determination of azithromycin in its pharmaceutical dosage forms. In the 
proposed method, azithromycin is oxidized with potassium permanganate to liberate 
formaldehyde, which is determined in situ using acetyl acetone, in the presence of 
ammonium acetate. A yellow colouredchromogen was obtained, having an absorption 
maxima at 412 nm. The method is found to be linear in the concentration range of 10-75 
µg/ml, with regression coefficient of 0.9978. Various reaction parameters such as 
concentration of potassium permanganate and reagent, time required for oxidation, and 
maximum colour intensity were optimized. The method was validated, and can be used 
successfully to assay azithromycin in its pharmaceutical dosage forms viz. tablets, 
capsules, and injections. 
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 Sachin Kumar Singh18,et al A RP-HPLC method was developed and validated for 
quantitative determination of azithromycin in pharmaceutical suspension dosage forms. 
The chromatography was carried out on a Phenomenex C 18 (150 x 4.6 mm i.d., 5µ) 
column with Acetonitrile: 0.5 % Formic acid as mobile phase (Isocratic A: B = 40: 60 % 
v/v), at 215 nm detector wave length with a flow rate of 1 ml/min. Clarithromycin was 
used as an internal standard. The linearity was established in the range of 20 - 600 ng/ml 
for HPLC. The HPLC method was accurate and precised for azithromycin suspension 
with a recovery of 98.75 to 99.44%. The spiked sample solutions were stable upto 1 
month. This validated method can be used for estimation of azithromycin in 
pharmaceutical suspension. 
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Molecular formula               :
Structure                               :
 
Chemical name                    :(S)
-1-yl)-7-oxo-7H-pyrido[1,2,3-de]
carboxylic acid 
Molecular weight              :  
Solubility:soluble in water and methanol
Melting range                
Pka:5.5 to 7.5 
Category                           
Quinolones, 
 Nucleic Acid Synthesis Inhibitors,
Anti-Infective Agents. 
 
 
2.1DRUG PROFILE 
LEVOFLOXACIN 
C18H20FN3O4 
Levofloxacin 
 
-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperzin
-1,4-benzoxazine-6- 
361.3675 
 
    :  218 ºC 
:Anti-Bacterial Agents, 
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Pharmacokinetic data     
Bioavailability                :99% 
Protein binding              :24 to 38% 
Metabolism        :Renal 
Half life:6 to 8 hours 
Excretion                        :Urinary 
Dosage form                    :tablet 
Dose :250 mg to 750 mg 
 Mechanism of action        :  
Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and DNA 
gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subunits of DNA 
gyrase, two subunits encoded by the gyrA gene. This results in strand breakage on a 
bacterial chromosome, supercoiling, and resealing; DNA replication and transcription 
is inhibited. 
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AZITHROMYCIN
 
Molecular formula               :    
 
Structure                               :   
Chemical name                    
3,4,10-trihydroxy-3,5,6,8,10,12,14
(dimethylamino)-β-D-xylo
methyl-3-O-methyl-α-L
Molecular weight              :
Solubility:rapidly soluble in methanol , Acetonitrile and partially 
                                                                  
Melting range :  113–115◦C 
Pka:8.74 
 
 
C38H72N2O12 
Azithromycin 
:  (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R
-heptamethyl-15-oxo- 11-{[3,4,6-trideoxy
-]oxy}-1-oxa-6-azacyclopentadec-13-yl 2,6-
-ribo-hexopyranoside 
748.9845 
 
Soluble in water 
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)-2-ethyl-
-3-
dideoxy-3-C-
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Category :Anti-Bacterial Agents 
Other Macrolides 
Macrolides 
 
Pharmacokinetic data     
  Bioavailability                 :  38% for 250 mg capsules 
  Protein binding            :   decreasing from 51% at 0.02 µg/mL to 7% at 2 µg/mL. 
  Metabolism                      : Hepatic 
Half life                           :  68 h 
  Excretion                         : Biliary, Renal (4.5%) 
  Dosage form                     :  tablet 
  Dose                                 :adult dose is 500-2000 mg 
Mechanism of action          :  
Azithromycin prevents bacteria from growing by interfering with their protein 
synthesis. It binds to the 50S subunit of the bacterial ribosome, and thus 
inhibits translation of mRNA. Nucleic acid synthesis is not affected. 
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 3. AIM & OBJECTIVE 
The literature review had showed that there are few individual reported methods for the 
determination of Levofloxacin and Azithromycin by RP-HPLC in pharmaceutical dosage 
forms.But there is no evidence available for simultaneous estimation for the above 
combination by RP-HPLC. Hence an attempt was made to develop a simple, precise, 
accurate, and economical RP-HPLC method for determination ofLevofloxacin and 
Azithromycin in pharmaceutical formulation. 
PLAN OF WORK: 
To develop a new RP-HPLC method for the estimation of LevofloxacinandAzithromycin 
pharmaceutical dosage form. 
 Study of physico chemical properties of drug(pH, pka,solubility, etc.,)  
 Selection of chromatographic condition ( Mobile phase, column, flow rate, etc.,) 
 Optimization of method. 
 Study of system suitability parameters. 
 Validation of proposal method. 
 Applying developed ,method to marketed formulation 
To validate the developed method by determining the validation parameters like Accuracy, 
 Precision, 
 Linearity, 
 Limit of detection, 
 Limit of quantification, 
 Robustness, 
 System suitability, 
 Force degradation studies. 
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           4. EXPERIMENTAL PART 
4.1  MATERIALS AND INSTRUMENTS 
Drug samples 
Levofloxacin and Azithromycinwere generously given by Rainbow pharma training 
laboratories, Hyderabad. 
Table no. 4.1 purity of working standards: 
 
Drug name 
 
Purity 
 
Levofloxacin 
 
99% 
 
Azithromycin 
 
99% 
 
Tablets used : 
BRAND:      LEVOMAC-AZ 
 Each tablet contains: 
Levofloxacin             -       500mg and 
Azithromycin     -       500mg 
 
          Chapter- 4                                                            Materials and instruments             
 
R.V.S college of pharmaceutical sciences                                Page no: 35 
 
Chemicals and solvents used : 
Water for HPLC 
Acetonitrile HPLC grade 
Sodium hydroxide 
Hydrochloric acid 
Milli Q water 
Potassium Di hydrogen phosphate 
Hydrogen peroxide 
Levofloxacin Working standard 
Azithromycin Working standard 
 
Instruments Used : 
Sartorius electronic balance 
LABINDIA pH meter 
“FAST – CLEAN” Ultrasonic cleaner 
Millipore – solvent filtration unit 
Waters e 2695 separations module 
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                               4.2METHOD DEVELOPMENT 
The objective of this experiment was to optimize the assay method for estimation of 
Levofloxacin and Azithromycin based on the literature survey. So here the trials 
mentioned describes how the optimization was done. 
 
TRAIL-1: 
Buffer preparation: 
Weigh accurately 6.80 g of Potassium Di hydrogen phosphate and  8.709 Di Potassium 
hydrogen phosphate dissolve it in 1000 ml of Milli-Q water. Adjust the pH to 6.5, filter 
through 0.45µm nylon membrane filter and degas. 
 
Chromatographic conditions: 
Flow rate                        :  1.0 ml/min 
Column                             :Hypersil  C18 ( 150 x 4.6 mm, 5µ) 
Detector wave length      :  285 nm 
Column temperature     :  350c 
Injection volume             : 10µl 
Run time                          :  10 mins 
Diluent                            : Mobile phase 
Mobile phase: pH 6.5 buffer : Acetonitrile (50:50) 
 
Chromatogram : 
 
                                                                             Figure no.4.2.1 
 
Isocratic system:  
AU
0.00
0.05
0.10
Minutes
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00
        Chapter – 6                                                                       Method Development 
 
R.V.S college of pharmaceutical sciences                                               Page no: 37 
 
Table- 4.2.1      
S.NO Name of the peak Retention time(min) 
1 
2 
 
Levofloxacin 
Azithromycin 
3.9 
 4.1 
 
Result : 
It fails system suitability parameters. In second trail –  changing of pH 
TRIAL-2: 
Buffer preparation: 
 Weigh accurately  6.80 g of Potassium Di hydrogen phosphate& 8.709 g of Di 
Potassium hydrogen phosphate and dissolve it in 1000 ml of Milli-Q water. Adjust the 
pH to 5.7, filter through 0.45µm nylon membrane filter and degas. 
 
Chromatographic conditions: 
Flow rate                        :  1.0 ml/min 
Column                           :c18 (Hypersil, 4.6 x 250mm, 5µm,) 
Detector wave length      :  285 nm 
Column temperature     :  350c 
Injection volume             : 10µl 
Run time                          :  10 mins 
Diluent                            :  Mobile phase 
Mobile phase: pH 5.7 buffer : acetonitrile (50:50) 
Chromatogram : 
 
                                                         Figure no 4.2.2 
Isocratic system :  
AU
0.00
0.05
0.10
Minutes
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00
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            Table- 4.2.2 
S.NO Name of the peak Retention time(min) 
1. 
2 
 
Levofloxacin 
Azithromycin 
4.3 
4.6 
Result: 
 The system suitability parameters are failed. In third trail – changing of pH and mobile 
phase ratio 
TRIAL-3: 
Buffer preparation: 
Weigh accurately  6.80 g of Potassium Di hydrogen phosphate & 8.709 g of Di 
Potassium hydrogen phosphate and dissolve it in 1000 ml of Milli-Q water. Adjust the 
pH to 7.3, filter through 0.45µm nylon membrane filter and degas. 
Chromatographic conditions: 
Flow rate                        :  1.0 ml/min 
Column                           : C18 (Hypersil 4.6 x 250mm, 5µm,) 
Detector wave length      :  285 nm 
Column temperature     :  350c 
Injection volume             : 10µl 
Run time                          :  9mins 
Diluent                            : Mobile phase 
Mobile phase: pH 7.3 buffer : Acetinitrile (70:30) 
Chromatogram : 
 
                                                             Figure no 4.2.3 
Isocratic programme:  
AU
0.000
0.010
0.020
0.030
0.040
Minutes
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00
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Table – 4.2.3 
S.NO Name of the 
peak 
Retention 
time(min) 
1 
2 
 
Levofloxacin 
Azithromycin 
7.1 
           8.5 
Result: 
       The peak height and shape was good and system suitability parameters are failed.in 
fourth trail changing of mobile phase ratio. 
TRIAL-4: 
Buffer preparation: 
Weigh accurately  6.80 g of Potassium Di hydrogen phosphate & 8.709 g of Di Potassium 
hydrogen phosphate and dissolve it in 1000 ml of Milli-Q water. Adjust the pH to 7.3, filter 
through 0.45µm nylon membrane filter and degas. 
Chromatographic conditions: 
Flow rate                        :  1.0 ml/min 
Column                           : C18 (Hypersil 4.6 x 250mm, 5µm,) 
Detector wave length      :  285 nm 
Column temperature     :  350c 
Injection volume             : 10µl 
Run time                          :  9mins 
Diluent                            : Mobile phase 
Mobile phase: pH 7.3 buffer : Acetinitrile (60:40) 
Chromatogram: 
 
                    Figure no. 4.2.4        
Isocratic programme:  
LE
VO
FL
O
XA
CI
N 
-
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72
4
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O
M
YC
IN
 
-
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84
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0.020
0.030
0.040
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00
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Table – 4.2.4 
S.NO Name of the 
peak 
Retention 
time(min) 
1 
2 
 
Levofloxacin 
Azithromycin 
           5.7 
           6.8 
Result: 
The peak height and shape was good and system suitability parameters are passed. 
OPTIMIZED METHOD: 
Buffer preparation: 
Weigh accurately  6.80 g of Potassium Di hydrogen phosphate & 8.709 g of Di Potassium 
hydrogen phosphate and dissolve it in 1000 ml of Milli-Q water. Adjust the pH to 7.3filter 
through 0.45µm nylon membrane filter and degas. 
 
Chromatographic conditions: 
Flow rate                        :  1.0 ml/min 
Column                           : C18 (hypersil 4.6 x 250mm, 5µm,) 
Detector wave length      :  285 nm 
Column temperature     :  350c 
Injection volume             : 10µl 
Run time                          :  9mins 
Diluent                            : Mobile phase. 
Mobile phase: pH 7.3 buffer : Acetinitrile (60:40) 
Chromatogram: 
 
                                                       Figure no. 4.2.5 
 
LE
VO
FL
O
XA
CI
N 
-
 
5.
72
4
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IT
HR
O
M
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-
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8
AU
0.000
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0.020
0.030
0.040
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00
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      Table – 4.2.5 
 Name Retention Time Area % Area Height USP Resolution s/n USP Tailing USP 
Plate 
Count 
1 LEVO 5.721 317720 40 35715          4.712 86.962 0.835 11519 
2 AZIT 6.848 464547 60 44659  108.082 0.874 11695 
 
 
Result: 
The system suiability parameters have been passed for above method. So we can use it as 
optimized method. 
 
ASSAY OF FORMULATION  BY DEVELOPED  METHOD: 
Preparation of buffer: 
Weigh accurately  6.80 g of Potassium Di hydrogen phosphate & 8.709 g of Di Potassium    
hydrogen phosphate and dissolve it in 1000 ml of Milli-Q water. Adjust the pH to 7.3.  
Mobile phase preparation: Mix up 600ml of Buffer and 400ml of Acetonitrile  
anddegass to remove air bubbles. 
Standard preparation: 
Transfer about 10 mg of Levofloxacin working standard and 10 mg of Azithromycinin to 
100ml volumetric flask, dissolve and dilute to volume with water and mixed.  
Test preparation: 
For estimating the tablet dosage form  randomly select 5 tablets(LEVOMAC-AZ) from a 
batch and make it powder, and weigh accurately 2760 mg of powder(equivalent to 1000 
mg Levofloxacin and 1000 mg of Azithromycin) and transfer to 100ml volumetric flask. 
Then add 70 ml of water shake the flask on a rotator shaker for 30 min and sonicate for 15 
min with intermediate shaking. Keep the solution on a rotatory shaker for 30 min at 200 
rpm. Centrifuge the portion of above solution at 4000 rpm for 5 min. Pipette out 1 ml of 
above clear solution and transfer it to 100 ml volumetric flask and make up the volume 
with water. 
 
 
Assay formula: 
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        AT               WS           DT                          
--------------- x ----------x --------- x average weight of tablet 
        AS              DS           WT                   
Where,   
AT = Peak Area of sample solution. 
AS = Peak Area of standard solution. 
WS = Weight of working standard taken in mg 
WT = Weight of sample taken in mg  
DS = Dilution of Standard solution  
DT = Dilution of sample solution 
Acceptance criteria: The limit of assay is in between the 98% - 102% 
Table no 4.2.6 showing Assay Results of Levofloxacin&Azithromycin: 
 
DRUG PEAK 
AREA 
ASSAY % 
Levofloxacin 321745 99% 
Azithromycin 471405 99% 
 
Chromatogram showing for standard solution : 
 
                     Figure no 4.2.6 
Chromatogram showing for test solution: 
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Figure no 4.2.7 
 UV- spectrum of Levofloxacine and Azithromycin: 
 
 
5.725 Peak 1
300.8
357.0 383.1 397.6
AU
0.00
0.10
6.850 Peak 2
288.9
353.4 375.9 395.2
AU
0.00
0.10
0.20
nm
220.00 240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00 400.00
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4.3 METHOD VALIDATION 
 
 After the method development the method was validated in terms of parameters like 
Precision, Accuracy Specificity, Linearity, and Robustness,system suitability, stability 
etc. 
OPTIMIZED METHOD: 
Buffer preparation: Weigh 6.80 & 8.70 gm of KH2PO4& K2HPO4   in 1000ml of water 
and adjust the pH to 7.30with phosphate buffer and filter through 0.45µm nylon 
membrane filter and degas. 
Chromatographic conditions: 
Flow rate                        :  1.0 ml/min 
Column                           : C18 (Hypersil 4.6 x 250mm, 5µm,) 
Detector wave length      :  285 nm 
Column temperature     :  350c 
Injection volume             : 10µl 
Run time                          :  9 mins 
Diluent                            :  Mobile phase 
Mobile phase: pH 7.30 buffer :Acetinitrile (60:40) 
Isocratic programme:  
           Table no: 4.3.1 
 
 
s.no 
 
Name of the peak 
 
Retention time 
 
1 
 
2 
 
Levofloxacin 
 
Azithromycin 
 
5.710 
 
6.848 
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4.3.1 SYSTEM SUITABILITY : 
A Standard solution of working standard was prepared as per procedure and was injected 
six times into the HPLC system. The system suitability parameters were evaluated from 
standard Chromatograms obtained by calculating the % RSD of retention times, tailing 
factor, theoretical plates and peak areas from six replicate injections.  
Acceptance criteria:  
The % RSD for the retention times of principal peak from 6 replicate injections of each 
Standard solution should be not more than 2.0 % 
The number of theoretical plates (N) should be not less than 2000. 
 The resolution should be more than 2 
THEORETICAL PLATES: 
A standard solution of 10µlof Levofloxacin and Azithromycinwas injected, then the system 
suitability parameters were calculated from the chromatogram. 
Calculation of number of theoretical plates  
N/L = 5.54 (Ve /W ½)2 
Where:N=Number of theoretical plates  
L=Length of column (m) 
Ve=Elution volume of an unretained non interactive molecule  
H=Height of peak 
W1/2 =Width of the peak at half peak height  
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RESOLUTION: 
Resolution of the method was calculated by the formula. 
 R = 2 (t2 – t1)/ (w2 + w1) 
Where, t1 and t2are Retention times of the components. 
w1 + w2 are corresponding width at the bases of the peak of components. 
Method: 
Preparation of standard solution: 
Accurately weigh and transfer 10 mg of Levofloxacin and 10 mg of Azithromycin  working  
standards into a 100 ml clean dry volumetric flask add about 70 ml  of Diluent and sonicate 
for 30 mts  to dissolve it completely and make volume up to the mark with the same 
solvent. (Stock solution)  
Table No:4.3.1.1System suitability Parameters  
System 
Suitability 
Parameters 
 
Levofloxacin 
 
Azithromycin 
 
Resolution 
 
                              4.706 
 
Tailing Factor 
 
0.835 
 
0.874 
Number of 
theoretical 
Plates 
 
11519 
 
11695 
 
Retention time 
 
5.724 
 
6.848 
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Chromatogram showing system suitability testing of Standard Solution -1 
ofLevofloxacin and Azithromycin: 
 
                      Figure no: 4.3.1.1 
Chromatogram showing system suitability testing of Standard Solution2 -1 
ofLevofloxacin and Azithromycin: 
 
                      Figure no: 4.3.1.2 
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Chromatogram showing system suitability testing of Standard Solution2 -2 
ofLevofloxacin and Azithromycin: 
 
                    Figure no. 4.3.1.3 
Chromatogram showing system suitability testing of Standard Solution2 -3 
ofLevofloxacin and Azithromycin: 
 
                    Figure no: 4.3.1.4 
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Chromatogram showing system suitability testing of Standard Solution2 -4 
ofLevofloxacin and Azithromycin: 
 
                    Figure no: 4.3.1.5 
Chromatogram showing system suitability testing of Standard Solution2 -5 
ofLevofloxacin and Azithromycin: 
 
                        Figure 4.3.1.6 
 
4.3.2 ACCURACY: 
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Accuracy expresses the closeness of agreement between the value, which was accepted 
either as conventional true value or and accepted reference value (International standard 
e.g. pharmaceutical standard) and the value found (mean value) obtained by applying the 
test procedure a number of times. 
       To study reliability, suitability and accuracy of the method, recovery studies were 
carried out, by adding a known quantity of the standard to the pre analysed sample and 
recovery study were done. The recovery was carried out at 50%, 100%, 100% level and the 
contents were determined from respective chromatogram .From the results obtained we 
conclude that the method was accurate. 
 
Preparation of Standard stock solution:  
Accurately weigh and transfer 10 mg ofLevofloxacin and 10 mg of Azithromycin   working  
standards into a 100 ml clean dry volumetric flask add about 70 ml  of Diluent and sonicate 
for 30 mts  to dissolve it completely and make volume up to the mark with the same 
solvent. (Stock solution). 
Preparation Sample solutions: 
For preparation of 50% solution (With respect to target Assay concentration): 
Accurately weigh and transfer 5 mg of Levofloxacin and 5 mg of Azithromycinworking 
standard into a 100 ml clean dry volumetric flask add about 70 ml of Diluent and sonicate 
to dissolve it completely and make volume up to the mark with the same solvent. (Stock 
Solution). 
              Repeat the above procedure and  Prepare another 5 solutions.  
 
 
For preparation of 100% solution (With respect to target Assay concentration): 
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Accurately weigh and transfer 10 mg of Levofloxacin and 10 mg of Azithromycinworking 
standards into a 100 ml clean dry volumetric flask add about 70 ml of Diluent and sonicate 
to dissolve it completely and make volume up to the mark with the same solvent.(Stock 
solution) 
                    Repeat the above procedure and  Prepare another 2 solutions. 
 
 For preparation of 150% solution (With respect to target Assay concentration): 
Accurately weigh and transfer 15 mg of Levofloxacin and 15 mg of Azithromycinworking 
standards into a 100 ml  clean dry volumetric flask add about 70 ml of Diluent and sonicate 
to dissolve it completely and make volume up to the mark with the same solvent.(Stock 
 solution). 
                 Repeat the above procedure and  Prepare another 5 solutions  
Procedure: 
Inject the 10µl standard solution, Accuracy -50% for 6 times, Accuracy -100% for 3 times 
and Accuracy -100% for 6 times.   
Calculate the amount present and amount added for the Levofloxacin and Azithromycin 
formula =		
		
		
											100 
Acceptance criteria: 
The mean % recovery of  theLevofloxacin and Azithromycinat each level should be not 
less than 97.0% and not more than 103.0%. 
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Table no: 4.3.2 Showing results for % recovery studies for Levofloxacin and 
Azithromycin: 
 
 
Chromatogram for accuracy 50% - 1 solution: 
Spike  
level 
Inj. 
no 
LEVO 
Peak 
Area 
 
LEVO 
µgm/ml 
added 
LEVO 
µgm/ml 
found 
% 
recov
ery 
AZI 
Peak area 
AZI 
µgm/ml 
added 
AZI 
µgm/ml 
found 
% 
recove
ry 
% MEAN 
LEV AZI 
 
 
 
50% 
1 152252 48.065 46.95 98 228541 47.580 47.01 99  
 
 
100 
 
 
 
99 
2 154749 48.209 47.92 99 226084 47.722 46.51 97 
3 159354 48.245 49.14 102 228450 47.757 46.99 98 
4 156581 47.993 48.29 101 232162 47.509 47.76 101 
5 155679 48.029 48.01 100 230592 47.544 47.43 100 
6 155469 48.037 47.94 100 235627 47.551 48.47 102 
 
 
100% 
1 317762 99.056 97.99 99 469659 98.000 96.61 99  
99 
 
99 2 317787 99.077 98.00 99 469606 98.007 96.60 99 
3 321825 99.541 99.25 100 477889 98.004 98.30 100 
 
 
 
 
150% 
1 489645 147.424 151.00 102 718447 145.935 147.79 101  
 
 
102 
 
 
 
101 
2 491204 147.426 151.48 103 727905 145.935 149.73 103 
3 480293 147.435 148.11 100 726781 145.945 149.50 102 
4 498550 147.438 153.74 102 717654 145.939 147.62 101 
5 485500 147.442 149.72 102 710231 145.953 146.10 100 
6 488057 147.435 150.51 102 698460 145.945 143.67 98 
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                    Figure no: 4.3.2.1 
 
   Chromatogram for accuracy 50% - 2 solution: 
 
Figure no: 4.3.2.2 
Chromatogram for accuracy 50% - 3solution: 
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Figure no: 4.3.2.3 
Chromatogram for accuracy 50% - 4 solution: 
 
                    Figure no: 4.3.2.4 
  Chromatogram for accuracy 50% - 5 solution: 
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    Figure no: 4.3.2.5 
 
 Chromatogram for accuracy 50% - 6 solution: 
 
                    Figure no: 4.3.2.6 
 
  Chromatogram for accuracy 100% - 1 solution: 
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                    Figure no: 4.3.2.7 
      Chromatogram for accuracy 100% - 2  solution: 
 
                    Figure no: 4.3.2.8 
Chromatogram for accuracy100% - 3 solution: 
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                    Figure no: 4.3.2.9 
             Chromatogram for accuracy150% - 1 solution:  
 
                    Figure no: 4.3.2.10 
   Chromatogram for accuracy150% - 2 solution: 
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                    Figure no: 4.3.2.11 
 Chromatogram for accuracy150% - 3 solution: 
 
                    Figure no: 4.3.2.12 
 
Chromatogram for accuracy150% - 4 solution: 
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                    Figure no: 4.3.2.13 
             Chromatogram for accuracy150% - 5 solution: 
 
                                           Figure no: 4.3.2.14 
Chromatogram for accuracy150% - 6 solution:  
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                    Figure no: 4.3.2.15 
        Chromatogram showing for the Accuracy of Levofloxacin and Azithroycin: 
 
                                   Figure no: 4.3.2.16 
   4.3.3 PRECISION:  
LE
VO
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0.000
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0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
0.050
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0.065
0.070
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00
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The Precision of test method was done by performing assay on five replicate determination 
of sample preparation at test concentration level (as per method of analysis) and calculated 
relative standard deviation of assay results. 
              5 injections from standard solutions were injected and the peak areas were 
obtained and %RSD was calculated. System precision and method precision were 
determined.                      
               5 same concentrations of standard solution are  prepared with mobile phase. 10µL 
of the standard solutions were injected and chromatograms were recorded  and the average 
% RSD values of the results were calculated.  
 
Standard Deviation    
    S.D  = 1
)xx( 2i
−
−∑
n
 
      Where, x=Sample, 
xi=Mean value of samples.  
    n=number of samples.  
     Coefficient of variance / Relative standard deviation 
 
C.V =        Standard Deviation  
      Mean 
 
 
Procedure: 
X 100 
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2760 mg of sample into 100 ml of volumetric flask and add 30 ml of water and sonicateto 
dissolve and make up with the diluents. 
          Transfer the above solution   1 ml into 100 ml volumetric flask and dilute the 
volume with water. 
 
 
      Table no. 4.3.3.1System Precision Levofloxacin and Azithromycin: 
 
Sample 
No 
Area of Levofloxacin 
(mv) 
Area of 
Azithromycin(mv) 
1 321374 482012 
2 321580 495284 
3 322171 482143 
4 323889 486140 
5 316130 482704 
Mean 321029 485657 
Std .dev 2912 5641 
%RSD 0.9 1.2 
 
 
 
Table no. 4.3.3.2Method Precision of Levofloxacin and Azithromycin: 
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Sample 
No 
Area of Levofloxacin 
(mv) 
Area of 
Azithromycin(mv) 
1 324952 483236 
2 319273 474541 
3 329684 471291 
4 322242 455970 
5 312092 474530 
6 322226 468864 
Mean 321745 471405 
Std .dev 5884 8992 
%RSD 1.8 1.9 
 
Acceptance criteria: 
% Relative standard deviation of results should not be more than 2.0 %. 
 
 
 
 
 
Intermediate precision: (Intra day& Inter day studies) 
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Intra day studies: It was performed by applying the proposed method on same sample of 
solution on different days. 
Table 4.3.3.3Intra day Studies 
Day Peak area 
of 
Levofloxaci
n 
Mean %RSD Peak area of  
Azithromycin 
Mean % RSD 
 
 
Day 
1 
321745  
 
321726 
 
 
0.9 
482012  
 
482408 
 
 
1.2 
 
321699 482143 
321754 482704 
 
 
Day 
2 
319725  
 
319356 
 
 
1.05 
 
471945  
 
 471524 
 
 
 
1.3 
 
319122 471452 
319421 471254 
 
Interdaytudies::It was performed by applying the proposed method on same sample of 
solution on same day at 2 hrs interval. 
 
       Table 4.3.3.4  Interday Studies 
 
Time 
Area of  
Levofloxacin 
Mean % RSD Area of 
Azithromycin 
Mean % RSD 
 
 
 
0th hour 
321374 
 
321754 
 
0.90 
483149 
482971 1.20 
321580 482724 
322171 482965 
 
 
3rd hour 
322889 
  322025 
 
0.91 
482912 
482854 1.20 321029 482841 
321564 482754 
 
 
6th hour 
321523 
321839 0.90 
481452  
481685 
 
1.26 321421 481921 
322014 481854 
 
 
Chromatogram showing for precision 1: 
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                    Figure no: 4.3.3.1 
   Chromatogram showing for precision2: 
 
                    Figure no: 4.3.3.2 
 
Chromatogram showing for precision3: 
Chapter-7                                             Method Validation 
 
R.V.S college of pharmaceutical sciences                                      Page no: 66 
 
 
                    Figure no: 4.3.3.3 
Chromatogram showing for precision 4: 
 
                    Figure no: 4.3.3.4 
 
Chromatogram showing for precision 5: 
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                    Figure no: 4.3.3.5 
Chromatogram showing for precision 6: 
 
                    Figure no: 4.3.3.6 
 
 
4.3.4 LINEARITY &RANGE : 
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LINEARITY:  Linearity is the ability of the method to obtain test results that are directly 
proportional to the analyte concentration within a given range. 
RANGE: Range of analytical procedure is the interval between the upper and lower 
concentration of analyte in the sample (including concentrations) for which it has been 
demonstrated that the analytical procedure has a suitable level of precision, accuracy, and 
linearity. 
Preparation of 50% stock solution: 
Transfer the 5 mg of Levofloxacin and 5 mg of Azithromycinof working standards into 100 
ml volumetric flask and add 60 ml of water and sonicate  for 30 mts and dilute to make up 
with water up to mark.  
Preparation of 75% stock solution: 
Transfer the 7.5 mg of Levofloxacin and 7.5 mg of Azithromycinof working standards into 
100 ml volumetric flask and add 60 ml of water and sonicate  for 30 mts and dilute to make 
up with water up to mark.  
Preparation of 100% stock solution:  
Transfer the 10 mg of Levofloxacin and 10 mg of Azithromycinof working standards into 
100 ml volumetric flask and add 60 ml of water and sonicate  for 30 mts and dilute to make 
up with water up to mark.  
Preparation of 125% stock solution: 
Transfer the 12.5 mg of Levofloxacin and 12.5 mg of Azithromycinof working standards 
into 100 ml volumetric flask and add 60 ml of water and sonicate  for 30 mts and dilute to 
make up with water up to mark.  
 
 
Preparation of 150% stock solution: 
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Transfer the 15 mg of Levofloxacin and 15 mg of Azithromycinof working standards into 
100 ml volumetric flask and add 60 ml of water and sonicate  for 30 mts and dilute to make 
up with water up to mark.  
Procedure:  
place each level into the chromatographic system and measure the peak area. 
Plot a graph of peak area vs concentration (on X-axis concentration and on Y-axis Peak 
area) and calculate the correlation coefficient. 
                 The linearity of calibration curves (analyte to peak area ratio Vs concentration) 
in pure solution was checked over the concentration ranges of 50 - 150 µg/ml for the 
Levofloxacin and 50-150 µg/ml for Azithromycinrespectively. The linearity was evaluated 
by linear regression analysis, using least squares method.  
The calibration curves were linear in the studied range and equations of the regression 
analysis obtained for Levofloxacin and AzithromycinY = 3130.x+1350(r2 = 0.999), and Y 
= 4697.x+2014  (r2 = 0.999) respectively.The mean ± standard deviation (SD) for the slope,  
and correlation coefficient of standard curves were calculated. 
  The slope and Correlation coefficient values for Levofloxacin were found to be 3130 and 
0.999 respectively.  
  The slope  and Correlation coefficient values for Azithromycinwere found to be 4697 
and 0.999 respectively. 
 
 
 
 
 
Table no: 4.3.4.1Linearity data for Levofloxacin and Azithromycin: 
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Concentration of 
Levofloxacin (%) 
50% 
75% 
100% 
125% 
100% 
 
 Linearity of Levofloxacin: 
 
Figure no: 4.3.4.1 
 Linearity of Azithromycin: 
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Peak Area of 
Levofloxacin 
(Mv) 
Concentration of  
Azithromycin(%) 
Peak Area of
Azithromycin
(Mv)
161184 50% 234242
234183 75% 345290
317107 100% 469082
387932 125% 579692
472914 100% 708226
y = 3130.x + 1350.
R² = 0.999
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                    Figure no: 4.3.4.2 
Table no. 4.3.4.2Analytical performence parameters for Levofloxacin and   
Azithromycin:                   
parameters Levofloxacin Azithromycin 
Lineariy range 50 – 150% 50 – 150% 
Correlation 
coefficient 
0.999 0.999 
slope 3130 4697 
 
Acceptance criteria: 
Correlation Coefficient (r2) should be not less than 0.9990. 
Chromatogram forLinearity of 50% solution: 
y = 4697.x - 2014.
R² = 0.999
-100000
0
100000
200000
300000
400000
500000
600000
700000
800000
0 20 40 60 80 100 120 140 160
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                    Figure no: 4.3.4.3 
Chromatogram for  Linearity of 75% solution: 
 
                    Figure no: 4.3.4.4 
Chromatogram forLinearity of 100% solution: 
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                    Figure no: 4.3.4.5 
 
Chromatogram forLinearity of 125% solution: 
 
                    Figure no: 4.3.4.6 
Chromatogram forLinearity of 150% solution: 
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                    Figure no: 4.3.4.7 
Linearity chromatogram for Levofloxacin and Azithromycin 50 – 150 % solution: 
 
                                                                       Figure no:4.3.4.8 
4.3.5 SPECIFICITY : 
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Specificity is the ability to assess unequivocally the analyte in the presence of components 
which may be expected to be present. Typically these might include impurities, degradants, 
matrix, etc.  
         The specificity study was carried out to check the interference from the excipients 
used in the formulations by preparing synthetic mixture containing both the drugs and 
excipients. The chromatogram showed peaks for both the drugs without any interfering 
peak. 
Determination: 
Placebo solution was prepared by mixing all the excepients used in the formulation.It was 
then injected into HPLC system. Blank solution was also injected into HPLC. 
Standard solution preparation: 
Accurately 10 mg of Levofloxacin and 10 mg of Azithromycinwere weighed and 
transferred into 100 ml volumetric flask, about 70ml of diluent was added and sonicated for 
30 minutes to dissolve it. The volume was made up with diluent. The solution was filtered 
through 0.45µm membrane filter (Stock solution).  
Inject 10µl of standard solution into HPLC system. Compare the chromatograms visually 
and check for any interference. 
Acceptance criteria: 
There should not be any peak in the blank & Placebo solution run at the retention time 
corresponding to Levofloxacin and Azithromycinas in standard run. 
 
 
 
 
Chromatogram showing for specificity – blank solution: 
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                    Figure no: 4.3.5.1 
Chromatogram showing for specificity – placebo solution: 
 
               Figure no: 4.3.5.2 
 
Chromatogram showing for the specificity – standard solution : 
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                                           Figure no: 4.3.5.3 
 
4.3.6 ROBUSTNESS : 
For demonstrating the robustness of the developed method experimental conditions were 
purposely altered and evaluated. The method must be robust enough to withstand such 
slight changes in chromatographic conditions and allow routine analysis of the sample. 
Effect of column temperature, and flow rate change were carried out and standard was 
injected. There was no change in system suitability parameters. 
 
               Flow rate change         -     ± 0.2 ml/min 
               Temperature change    -     ± 50c  
 
 
 
Table no. 4.3.6. Robustness studies showing of Levofloxacin and Azithromycin.   
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Effect  
 
            Retention time        
 
           Tailing  
 
        Plate count 
 
LEVO 
 
AZI 
 
LEVO 
 
AZI 
 
LEVO 
 
AZI 
Folw rate 
0.8µl 
6.467 7.580 0.878 0.863 12944 13093 
Flow rate 
1.2µl 
5.120 6.148 0.902 0.970 11426 11882 
Temperature 
300c 
8.481 10.214 0.832 0.831 13844 13275 
Temperature 
400c  
5.120 6.148 0.832 0.831 11426 11882 
 
 
Acceptance criteria : 
It should pass system suitability parameters 
 
 
 
 
Chromatogram showing for robustness flow 1: 
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                    Figure no: 4.3.6.1 
Chromatogram showing for robustness flow 2: 
 
          Figure no: 4.3.6.2 
Chromatogram showing for robustness temp 1: 
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                    Figure no: 4.3.6.3 
Chromatogram showing for robustness temp 2: 
 
                    Figure no: 4.3.6.4 
 
4.3.7  LOD& LOQ: 
LIMIT OF DETECTION : 
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Limit of detection is the  
lowest concentration of the analyte that can be detected by injecting decreasing amount, not 
necessarily 
quantity by the 
method, under 
the stated experimental conditions. The minimum concentration at which the analyte can be 
detected is determined from the linearity curve by applying the formula. 
              LOD        =    3/s/n ratio x  drug concentration 
            The lowest concentration of Levofloxacin  that can be detected was determined 
from standard curve was 3.499µg/ml. 
            The lowest concentration of Azithromycinthat can be detected was determined from 
standard curve was 2.775µg/ml. 
 
LIMIT OF QUANTIFICATION : 
Limit of quantitation is the lowest concentration of the analyte in a sample that can be 
estimated quantitatively by injecting decreasing amount of drug with acceptable precision 
and accuracy under the stated experimental conditions of the method .Limit of 
quantification can be obtained from linearity curve by applying the following formula. 
                   LOQ   = 10/s/n ratio x drug conc. 
                  The lowest concentration at which peak can be quantified is called LOQ. It was 
found to be 11.499µg/ml for Levofloxacin and for Azithromycinwas found to be 
9.252µg/ml.        
 
 
 
Sample LOD LOQ 
Chapter-7                                             Method Validation 
 
R.V.S college of pharmaceutical sciences                                      Page no: 82 
 
Table no. 
4.3.7 LOD & 
LOQ results 
showing for 
Levofloxacin 
andAzithromycin: 
 
 
 
 
 
 
 
Chromatogram for limit of detection : 
 
Levofloxacin 3.449µg/ml 2.775 µg/ml 
Azithromycin 
 
11.499µg/ml 9.252µg/ml 
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 Figure no: 4.3.7.1 
 
 
Chromatogram for limit of quantification : 
 
Figure no: 4.3.7.2 
4.3.8  DEGRADATION STUDIES : 
ACID(0.1N HCL): 
Test preparation: 
             Randomly select 20 tablets from a batch and make it powder, and weigh accurately 
2760 mg of powder(equivalent to 1000 mgof Levofloxacin and 1000 mg of Azithromycin) 
and transfer to 100ml volumetric flask. Then add 10ml of acid(0.1N HCL), shake the flask 
on a rotator shaker for 30 min and sonicate for 1hr  with intermediate shaking then add 
10ml base(0.1NaOH) and make up the volume with water. 
          Pipette out 1 ml of above clear solution and transfer it to 100 ml volumetric flask and 
make up the volume with water.   Inject 10µl of test solution into HPLC system. 
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BASE(0.1N NaOH): 
Test preparation: 
              Randomly select 20 tablets from a batch and make it powder, and weigh 
accurately 2760 mg of powder(equivalent to 1000 mg of Levofloxacin and 1000 mg of 
Azithromycin) and transfer to 100ml volumetric flask. Then add 10ml of base(0.1NaOH) , 
shake the flask on a rotator shaker for 30 min and sonicate for 1hr  with intermediate 
shaking then add 10ml acid(0.1N HCL),   and make up the volume with water. 
 
 Pipette out 1 ml of above clear solution and transfer it to 100 ml volumetric flask and 
make up the volume with water.   Inject 10µl of test solution into HPLC system. 
 
PEROXIDE: 
Test preparation 
Randomly select 20 tablets from a batch and make it powder, and weigh accurately 2760 
mg of powder(equivalent to 1000 mg of Levofloxacin and 1000 mg of Azithromycin) and 
transfer to 100ml volumetric flask. Then add 0.1ml peroxide  shake the flask on a rotator 
shaker for 30 min and sonicate for 1hr  with intermediate shaking  and make up the volume 
with water. 
 
 Pipette out 1 ml of above clear solution and transfer it to 100 ml volumetric flask and 
make up the volume with water.   Inject 10µl of test solution into HPLC system. 
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LIGHT: 
Test preparation 
Randomly select 20 tablets from a batch and make it powder, and weigh accurately 2760 
mg of powder(equivalent to 1000 mg of Levofloxacin and 1000 mg Azithromycin) and 
transfer to 100ml volumetric flask. Then shake the flask on a rotatorshaker for 30 min and 
sonicate for 1hr  with intermediate shaking  and make up the volume with water. 
 
 Pipette out 1 ml of above clear solution and transfer it to 100 ml volumetric flask and 
make up the volume with water.   Inject 10µl of test solution into HPLC system. 
 
WATER: 
Test preparation 
Randomly select 20 tablets from a batch and make it powder, and weigh accurately 2760 
mg of powder(equivalent to 1000 mg Levofloxacin and 1000 mg of Azithromycin) and 
transfer to 100ml volumetric flask. Then shake the flask on a rotator shaker for 30 min and 
sonicate for 1hr  with intermediate shaking  and make up the volume with water. 
 
Pipette out 1 ml of above clear solution and transfer it to 100 ml volumetric flask and make 
up the volume with water.   Inject 10µl of test solution into HPLC system. 
Acceptance criteria: 
The net Degardation Should be between 1% to 50%. 
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Assay formula: 
 AT               WS           DT    average wt of tablet 
 --------------- x ----------x --------- x  ----------------------x working standard.      
       AS             DS          WT          lable claim 
Where,   
 AT = Peak Area of sample solution. 
 AS = Peak Area of standard solution. 
 WS = Weight of working standard taken in mg 
 WT = Weight of sample taken in mg  
 DS = Dilution of Standard solution  
 DT = Dilution of sample solution 
Table no. 4.3.8.Degradation studies showing for the Levofloxacin and Azithromycin: 
 
 
Test  
Area of  
LEVO 
Area of  
AZI 
% Asaay 
of LEVO 
% Assay  
of AZI 
% deg of  
LEVO 
% deg of  
AZI 
Acid  276538 449569 85 92 -14 -6 
Base  279241 417170 86 85 -13 -13 
Peroxide  273317 430256 84 88 -15 -10 
Light 264009 399956 81 81 -18 -17 
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Water 295093 422565 90 86 -8 -11 
Avg assay     86 86 -13 -12 
 
Chromatogram showing peaks of acid solution of Levofloxacin and Azithromycin : 
 
Figure no: 4.3.8.1 
Chromatogram showing peaks of base solution of Levofloxacin and Azithromycin : 
 
Figure no: 4.3.8.2 
Chromatogram showing peaks of peroxide solution of Levofloxacin and Azithromycin : 
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Figure no: 4.3.8.3 
Chromatogram showing peaks of light solution of Levofloxacin and Azithromycin : 
 
Figure no: 4.3.8.4 
 
 
Chromatogram showing peaks of water solution of Levofloxacin and Azithromycin: 
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Figure no: 4.3.8.5 
Chromatogram showing for the method validation for Levofloxacin and 
Azithromycin: 
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5.RESULTS AND DISCUSSION 
 
 After several trails with various solvents, mobile phase system composed of 
KH2PO4& K2HPO4 buffer and acetonitrilein the proportion of 60:40%v/v. 
respectively was chosen for the simultaneous estimation of Levofloxacin and 
Azithromycin in combined dosage form by RP-HPLC. This mobile phase 
composition offered maximum resolution for the drug at the detection wavelength of 
285nm.The column used was C18hypersil (250 × 4.6mm) with flow rate of 1.0 ml/min 
and UV Detection was carried out. 
 
The individual peaks ofLevofloxacin and Azithromycin were identified by knowing 
the retention time 5.72 and6.84 minutes respectively. 
 
The results of analysis shows that the amount of drugs was in good agreement with 
the label claim of the formulation. The tablet shows percentage purity values ranging 
from 99% of Levofloxacine and 98% of Azithromycinrespectively. 
 
For the System suitability studies were carried out in which the resolution 
between the peaks, tailing factor and number of theoretical plates was found and these 
are within the limit. 
 
For the Accuracy of the method was determined by performing recovery 
studies at 50%, 100%, 150%. The recovery study was carried out and results were 
expressed in terms of the percentage recovery range found to be within the limit.  
 
For System Precision studies, the standard solution was prepared at working 
concentration and analysis was carried for five replicated injections. The percentage 
relative standard deviation (% RSD) was calculated for the peak areas for 
Levofloxacin and Azithromycin 0.9 and 1.2 and it was  not more than 2.0%. 
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 The acceptance criterion of method precision was found to be %RSD NMT 
2.0% and the Method Precision for   Levofloxacin and Azithromycin shows 1.8 and 
1.9and it was not more than 2.0%. 
 
 
The Linearity for the both drugs, From the calibration curve constructed by plotting 
concentration vs. peak area, it was found that there exists a linear relationship in the 
concentration range 50 to 150µgm/ml  and 50 to 150µgm/ml for Levofloxacin and 
Azithromycin, with 0.999 and 0.999 as the value of correlation coefficient for the both 
drugs respectively  as These are observed within Limit. 
 
The Robustness of the method was by changing the parameters like flow rate and 
changing the column temperature and the result was found to be within limit. The 
method shows no change in the system suitability and precision parameters. 
 
The Limit of Detection (LOD) and Limit of Quantitation (LOQ) Of the 
developed method were determined by injecting progressively low concentrations of 
the standard solutions using the developed RP-HPLC method .The LOD is the 
smallest concentration of the analyte that gives a measurable response (signal to noise 
ratio of 3).The detection limit (LOD) was found to be 3.449µg/ml for Levofloxacin 
and 2.775µg/mlforAzithromycinrespectively. 
 
 The LOQ is the smallest concentration of the analyte, which gives response 
that can be accurately quantified (signal to noise ratio of 10).The quantification limit 
(LOQ) was found to be 11.499µg/ml for Levofloxacin and 9.252µg/ml for 
Azithromycin respectively. 
 
             The percentage degradation of Levofloxacin and Azithromycin Parameters 
like Acid, Base, Peroxide, Light, and Water studies were found to be within 
the limits.  
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 The Linearity, precision, accuracy, specificity, repeatability of measurement of 
peak area as well as repeatability of sample applications are validated as per ICH 
guidelines and the results are shown in the following Table.5.1 
 
S.NO 
 
Parameter 
 
Limits 
Observation 
LEVO AZIT 
1 
 
Specificity 
 
No interference 
No 
interference 
No 
interference 
2 
System precision 
Method precision 
 
RSD NMT     2.0% 
0.8 
1.8 
1.2 
1.9 
3 
 
Linearity range 
Correlation 
coefficient NMT –
0.999 
 
0.999 
 
0.999 
4 
 
Accuracy 
 
% Recovery     
range     98 –102 % 
 
100.3 
 
99.6 
5 
 
Limit of Detection 
Signal noise ratio 
should be more 
than 3:1 
 
3.449 
µg/ml 
 
2.775 µg/ml 
6 
 
Limit of Quantitation 
 
 
Signal noise ratio 
should be more 
than 10:1 
 
 
11.499 
µg/ml 
 
 
9.252 µg/ml 
7 
Number of 
Theoretical Plates 
 
NLT 2000 
 
11519 
 
11695 
8 
 
Robustness 
Change in column 
temperature, 
Change inflow 
 No effect on 
system 
suitability 
parameters 
No effect on 
system 
suitability 
parameters 
9 Forced degradation 1 - 50% pass pass 
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6.CONCLUSION 
             The results obtained by the proposed method for determination of 
Levofloxacin and Azithromycin by RP-HPLC mehod are reliable, accurate, and 
precise. The values of standard deviation were found satisfactory and the recovery 
studies were close to 100%. The method does not require prior separation of one drug 
from other. System suitable parameters, precision, linearity, accuracy, precision, 
Robustness and stability according to ICH guidelines were found to be satisfactory. 
The proposed method was simple, specific, requires short time to analyse samples and 
easy to perform. 
Future :  
 Hence it was concluded that the RP-HPLC method developed was very much suitable 
for routine analysis ofLevofloxacin and Azithromycintablet formulations and future 
planning's use this method for estimation ofLevofloxacin and Azithromycin in clinical 
trials and Bio analytical studies. 
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